Literature DB >> 3939

Preliminary study of parenteral lorazepam in status epilepticus.

A Waltregny, J Dargent.   

Abstract

The authors report their experience with parenteral lorazepam in the acute treatment of 11 patients with EEG-confirmed status epilepticus. Ten adults and one 6-year-old child were injected respectively with 5 mg and 2.5 mg lorazepam. All of these patients exhibited prompt cessation of seizures both electrical and clinical. Some data indicate a longer lasting relief than that provided by an equal dose of diazepam.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 3939

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  4 in total

1.  Neurology-important advances in clinical medicine: Lorazepam: a new antiepileptic drug in status epilepticus therapy.

Authors:  N S Chu
Journal:  West J Med       Date:  1982-10

Review 2.  Lorazepam: a review of its clinical pharmacological properties and therapeutic uses.

Authors:  B Ameer; D J Greenblatt
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

3.  Epileptic seizure disorders. Developments in diagnosis and therapy.

Authors:  E Niedermeyer; W Froescher; R S Fisher
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

Review 4.  Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability.

Authors:  Adam Strzelczyk; Laurent M Willems; Ricardo Kienitz; Lara Kay; Isabelle Beuchat; Sarah Gelhard; Sophie von Brauchitsch; Catrin Mann; Alexandra Lucaciu; Jan-Hendrik Schäfer; Kai Siebenbrodt; Johann-Philipp Zöllner; Susanne Schubert-Bast; Felix Rosenow
Journal:  CNS Drugs       Date:  2022-08-16       Impact factor: 6.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.